Foghorn Therapeutics Cash Flow Statement (2019-2026) | FHTX

Cash Flow Statement Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
-23.76M-26.76M-28.51M-26.91M-27.31M-25.77M-28.89M-30.49M-29.49M-14.35M-24.11M-25.02M-22.98M-19.12M-19.50M-20.22M-18.79M-16.47M-22.17M-19.83M
Share-based Compensation (Quarter)
2.04M2.37M2.08M3.24M3.51M3.80M3.78M4.57M4.47M4.09M3.05M3.22M3.17M3.02M2.48M2.69M2.73M2.73M2.24M2.38M
Gains from Investment Securities (Quarter)
1.69M1.00M0.86M0.75M-0.75M1.21M-0.01M
Asset Writedowns and Impairment (Quarter)
2.40M5.91M
Cash from Operations (Quarter)
-18.48M-20.50M11.88M271.53M-29.01M-19.99M-28.92M-31.18M-32.17M-27.21M-27.54M-29.34M-25.54M-21.00M-24.52M-23.97M-21.00M-18.86M-22.27M-25.27M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
0.01M-0.10M-0.10M-0.04M0.33M0.43M0.57M0.77M0.73M0.66M0.49M0.55M0.70M1.78M1.57M0.82M0.45M0.36M0.31M0.39M
Amortization of Deferred Charges (Quarter)
0.09M0.09M0.06M
Depreciation & Amortization (CF) (Quarter)
0.80M0.80M0.81M0.80M0.80M0.90M0.85M0.90M0.80M0.90M0.90M0.80M0.80M0.70M0.76M0.83M0.90M0.90M0.77M0.24M
Change in Working Capital
Change in Account Payables (Quarter)
0.49M0.41M-0.02M1.27M-1.44M1.62M0.16M1.69M-0.17M-0.44M-0.24M-0.63M-0.83M-1.35M0.33M0.28M-0.75M-0.11M1.05M-0.99M
Change in Accured Expenses (Quarter)
0.91M1.95M2.40M-2.54M1.09M2.00M0.89M-2.15M-0.67M0.69M0.33M-2.81M-0.30M4.97M-2.42M-2.41M2.02M1.16M1.44M-4.46M
Other Working Capital Changes (Quarter)
-0.71M0.41M2.13M-3.92M3.96M-5.35M5.62M-1.67M1.04M-27.76M-5.77M-2.09M-9.85M9.38M-5.39M-1.07M-8.50M1.30M-21.30M0.09M
Investing Activities
Capital Expenditures (Quarter)
1.21M0.23M0.08M0.25M-0.04M0.73M0.27M0.30M-0.21M1.10M-1.15M0.10M0.01M0.18M0.62M0.03M0.02M-0.05M0.05M0.04M
Change in Acquisitions & Divestments (Quarter)
94.47M20.00M53.13M19.00M56.00M38.10M56.37M76.57M42.37M44.26M58.46M48.15M63.45M62.42M80.55M76.00M39.58M47.21M49.22M
Cash from Investing Activities (Quarter)
77.09M-47.33M9.67M-159.41M-124.46M46.05M-6.51M29.50M39.13M38.43M37.38M27.09M-17.98M-61.31M22.29M29.40M33.83M35.57M13.23M-17.72M
Financing Activities
Other financing activities (Quarter)
0.39M0.32M
Cash from Financing Activities (Quarter)
0.11M0.51M21.74M0.38M1.03M0.33M0.02M0.10M0.10M1.39M0.19M1.17M103.21M1.05M0.00M0.14M0.25M0.05M0.58M49.77M
Additional items
Change in Cash (Quarter)
58.72M-67.33M43.30M112.51M-152.44M26.40M-35.41M-1.57M7.06M12.60M10.03M-1.08M59.69M-81.27M-2.22M5.57M13.09M16.76M-8.46M6.79M
Free Cash Flow (Quarter)
-19.69M-20.73M11.80M271.29M-28.98M-20.72M-29.19M-31.48M-31.96M-28.31M-26.39M-29.45M-25.55M-21.18M-25.14M-24.00M-21.02M-18.81M-22.32M-25.30M
Net Cash Flow (Quarter)
58.72M-67.33M43.30M112.51M-152.44M26.40M-35.41M-1.57M7.06M12.60M10.03M-1.08M59.69M-81.27M-2.22M5.57M13.09M16.76M-8.46M6.79M